HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hari Krishna Nallapaneni Selected Research

KRC-108

7/2022Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hari Krishna Nallapaneni Research Topics

Disease

1Colonic Neoplasms (Colon Cancer)
07/2022
1Neoplasms (Cancer)
07/2022
1Wasting Syndrome (Wasting Disease)
07/2021

Drug/Important Bio-Agent (IBA)

1KRC-108IBA
07/2022
1Phospholipases (Phospholipase)IBA
07/2022
1Phosphotransferases (Kinase)IBA
07/2022
1Proteins (Proteins, Gene)FDA Link
07/2022
1Androgen Receptors (Androgen Receptor)IBA
07/2021